Pharmesis International Ltd. (SGX:BFK)

Singapore · Delayed Price · Currency is SGD

0.3100

+0.0100 (3.33%)

At close: Feb 19, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Distribution	21.03M	9.74M	-	-	3.99M
Distribution Growth	115.95%	-	-	-	-63.16%
TCM Formulated Drugs	18.84M	34.90M	36.72M	37.51M	32.25M
TCM Formulated Drugs Growth	-46.01%	-4.95%	-2.12%	16.30%	64.44%
Eliminations	-16.22M	-10.07M	-	-	-3.50M
Western Drugs	44.00M	11.07M	13.65M	15.26M	14.37M
Western Drugs Growth	297.52%	-18.93%	-10.53%	6.19%	-11.85%
Total	67.65M	45.64M	50.37M	52.77M	47.11M
Total Growth	48.24%	-9.40%	-4.55%	12.01%	26.64%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
People's Republic of China (PRC)	67.65M	45.64M	50.37M	52.77M	47.11M
People's Republic of China (PRC) Growth	48.24%	-9.40%	-4.55%	12.01%	26.63%
Total	67.65M	45.64M	50.37M	52.77M	47.11M
Total Growth	48.24%	-9.40%	-4.55%	12.01%	26.63%

Source: S&P Global Market Intelligence.